India’s Wockhardt Denies Report It Selling Assets To Mylan, Pfizer
This article was originally published in PharmAsia News
Executive Summary
India’s Wockhardt denied reports it was discussing selling some of its businesses to Mylan and Pfizer so it can concentrate on foreign markets.